Earnings Call Transcripts
Access detailed transcripts and key takeaways from company earnings calls
All Earnings Calls
Cryoport Q4 2025 Earnings Call - Commercial CGT Momentum and Path to Positive Adjusted EBITDA in H2 2026
Cryoport closed 2025 with revenue from continuing operations of $176.2 million, beating prior guidance and driven by accelerating commercial cell and gene therapy activity. Commercial revenue grew 29%...
- Continuing-operations revenue for full year 2025 was $176.2 million, above the high end of prior guidance.
- Commercial cell and gene therapy revenue increased 29% year-over-year and totaled a record $33.4 million for 2025, representing about 20% of total revenue.
- Clinical trial revenue grew 14% year-over-year to $47.1 million, and Cryoport concluded 2025 supporting a company-stated record 760 clinical trials and 20 commercial therapies worldwide.
- +12 more takeaways
California Resources Corporation Fourth Quarter 2025 Earnings Call - Record results, deeper inventory and CCS moving to commissioning
California Resources closed 2025 with production growth for the third straight year, record financials and a heavier return of cash to shareholders, all while oil prices were down 14% year over year. ...
- Third consecutive year of production growth in 2025, with net production up about 25% year over year to ~138,000 BOE/d for the full year.
- Record financial performance: full-year adjusted EBITDAX nearly $1.25 billion, free cash flow of $543 million; Q4 adjusted EBITDAX $251 million and Q4 free cash flow $115 million (including 14 days from Berry).
- Massive inventory disclosure: nearly 1.2 billion BOE of 2P reserves, which management says supports roughly 23 years of development at current production levels; 1P reserves grew 350% and have an implied SEC-value of about $9 billion.
- +12 more takeaways
StandardAero Q4 and Full Year 2025 Earnings Call - LEAP ramp drives revenue but dilutes margins until scale and repairs kick in
StandardAero closed 2025 as a record year, with revenue up about 16% and Adjusted EBITDA up 17%, while converting to meaningful cash flow. The company inducted 60 LEAP engines in 2025, ramped LEAP and...
- 2025 was a record year, revenue +15.8% and Adjusted EBITDA +17%, with full year net income of $277 million versus a loss in 2024.
- Free cash flow swung positive, $209 million for 2025 and a strong Q4 FCF of $308 million, driven by deliveries of engines stalled by parts delays and improved working capital.
- LEAP program ramped materially, with 60 engine inductions in 2025 versus 10 in 2024, H2 LEAP revenues roughly 2.5x H1, and the first full overhaul completed on the platform.
- +12 more takeaways
Compass, Inc. Q4 2025 Earnings Call - Rocket/Redfin alliance and fast-tracked Anywhere synergies aim to reshape inventory and margins
Compass closed 2025 on a high note, posting record Q4 revenue of $1.7 billion and adjusted EBITDA of $58.3 million, and a record full-year revenue of about $7 billion with $293 million adjusted EBITDA...
- Q4 revenue $1.7 billion, beating the high end of guidance; Q4 adjusted EBITDA $58.3 million, record for any Q4 and above guidance.
- Full-year 2025 revenue approximately $7 billion, a company record, with adjusted EBITDA $293 million and operating cash flow $217 million, all-time highs.
- Rocket Redfin three-year strategic alliance announced, expected to deliver 1.2 million high-intent leads to Compass agents over three years, with increasing lead flow each year and potential upside in year three.
- +16 more takeaways
Methanex Corporation Q4 2025 Earnings Call - Middle East supply disruption tightens market and lifts spot prices
Methanex reported Q4 2025 revenue drivers that look simple on the surface, but hide a more volatile market. Q4 average realized price was $331 per ton on produced sales of about 2.4 million tons, gene...
- Q4 average realized methanol price $331 per ton, produced sales ~2.4 million tons.
- Adjusted EBITDA for Q4 2025 was $186 million, with an adjusted net loss of $11 million.
- Management attributes q/q EBITDA decline to lower average realized price and immediate fixed cost recognition tied to plant outages in December.
- +14 more takeaways
ACG Q4 2025 Earnings Call - Revenues stable but one-time RMB33.9m goodwill hit turns an operational improvement into a quarterly loss
ACG reported Q4 2025 net revenue of RMB 89.1 million, down 11.7% year over year, while full-year revenue held flat at RMB 268.1 million. The headline swing to a Q4 net loss of RMB 26.3 million was dri...
- Q4 2025 net revenue RMB 89.1 million, down 11.7% year over year; full-year 2025 revenue RMB 268.1 million, essentially flat versus 2024.
- Q4 gross profit fell to RMB 30.2 million from RMB 63.7 million a year earlier, gross margin compressed to 56.4% from 63.1% due to higher outsourcing and part-time teacher costs.
- Company recorded a one-time goodwill impairment of RMB 33.9 million in Q4 2025, equivalent to about $4.8 million, which flipped operating income to a loss.
- +12 more takeaways
Journey Medical Full Year 2025 Earnings Call - EMROSI launch drives strong prescriptions and adjusted EBITDA positivity
Journey Medical used 2025 to reinvent itself around EMROSI, its new oral rosacea therapy. Launched commercially in April, EMROSI generated $14.7 million in net sales across three quarters, about 53,00...
- EMROSI commercial launch began in late March 2025, with promotion starting in April, and produced $14.7 million in net sales across the three quarters it was available last year.
- Total EMROSI prescriptions reached approximately 53,000 since launch, with about 3,500 unique prescribers having written at least one script to date.
- EMROSI prescription momentum accelerated in Q4, with Q4 prescriptions annualized to a run rate of roughly 126,000 scripts; management expects further sequential growth into 2026.
- +12 more takeaways
Stardust Power Inc. Year-end 2025 Earnings Call - Muskogee Refinery De-risked, Moving to Project Financing
Stardust used 2025 to methodically de-risk its planned Muskogee lithium refinery, checking engineering, permitting, supply and commercial boxes that lenders and strategic partners demand. Management s...
- Company completed FEL-3 engineering study for the Muskogee lithium refinery with Primero USA, a milestone management says is required to advance project planning and financing.
- Independent review by Black & Veatch concluded the project has low technical and design risk and that phase one production targets are achievable, providing third-party validation.
- Stardust secured an air quality construction permit from the Oklahoma Department of Environmental Quality, with the facility qualifying as a minor source under state and federal air rules, materially reducing regulatory timeline risk.
- +13 more takeaways
Dyadic International Inc. Full Year 2025 Earnings Call - Transitioning to Commercial Revenues with Early Product Launches and Runway into 2027
Dyadic spent 2025 moving from platform R&D to commercial execution, signing distribution and manufacturing partnerships, launching products, and booking grant funding. Revenues edged lower to $3.09 mi...
- Company repositioned as Dyadic Applied BioSolutions and signaled a strategic shift from development-stage platform work to commercial product sales and partner-driven revenues.
- Total 2025 revenue was $3.09 million, down from $3.5 million in 2024, driven by lower R&D collaboration and reduced license and milestone income, partially offset by increased grant revenue.
- Net loss for 2025 widened to $7.36 million, or $0.23 per share, compared to a $5.81 million loss in 2024, reflecting continued investment during the commercial transition.
- +11 more takeaways
Planet 13 Holdings Q4 2025 Earnings Call - Stabilization in Q4, 2026 pivot to positive cash flow after California exit and Nevada cuts
Planet 13 reported a stabilizing quarter as restructuring and portfolio cleanup began to show through the numbers. Revenue rose sequentially 8% to $25.2 million, retail drove the improvement and gross...
- Sequential revenue improvement, total Q4 revenue $25.2 million, up roughly 8% from Q3 ($23.3 million).
- Retail stabilization: SuperStore and neighborhood network combined $23.2 million vs $21.3 million in Q3; SuperStore (including DAZED) $9.2 million, essentially flat with Q3 despite F1 disruption.
- Florida momentum: Neighborhood stores generated $14 million with Florida at $10.3 million, though that figure included a one-time loyalty accrual adjustment; excluding California, non-SuperStore neighborhood stores grew about 8% sequentially.
- +12 more takeaways